How Ozempic Lowers Daily Blood Sugar
Ozempic (semaglutide) is a GLP-1 receptor agonist injected once weekly. It stimulates insulin release, slows gastric emptying, and reduces glucagon when blood sugar rises, lowering average daily glucose levels by 1.5-2% (HbA1c reduction) over time in type 2 diabetes patients.[1][2]
Duration of Effect After a Single Dose
After subcutaneous injection, peak plasma levels occur in 1-3 days. Blood sugar-lowering effects start within hours, peak around day 3-5, and persist for up to 7 days due to semaglutide's 165-hour half-life. Steady-state control is reached after 4-5 weekly doses, maintaining 24-hour coverage.[1][3]
Impact on Daily Blood Sugar Patterns
- Fasting glucose: Drops within 1-2 days, sustained through the week.
- Post-meal spikes: Reduced by 30-50% for 4-6 hours after meals, with blunting of spikes lasting the full dosing interval.
- 24-hour profile: Continuous glucose monitoring shows stable daily levels, with trough effects (end of week) still lowering glucose by ~20-30 mg/dL vs. placebo.[2][4]
Clinical trials (SUSTAIN program) confirm consistent daily control, with no significant rebound between doses.[2]
Factors Affecting Duration
Dose (0.25mg starting, up to 2mg weekly), food intake, kidney function, and anti-drug antibodies influence duration. In trials, effects wane minimally by day 7, supporting weekly dosing.[1][3]
What Happens If You Miss a Dose
Effects linger 5-7 days post-miss; inject ASAP if within 5 days, otherwise skip and resume schedule to avoid overlap.[1]
Comparison to Daily GLP-1 Options
Unlike daily liraglutide (Victoza, ~13-hour half-life with shorter daily coverage), Ozempic provides full-week stability, reducing fluctuations.[2]
[1]: Ozempic Prescribing Information (Novo Nordisk)
[2]: SUSTAIN Clinical Trials (NEJM)
[3]: Semaglutide Pharmacokinetics (Diabetes Care)
[4]: CGM Data in Semaglutide Trials (Diabetes Technology & Therapeutics)